Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lyka Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500259NSE Symbol: LYKALABSP/E(TTM):420.71
ISIN Demat:INE933A01014Div & Yield %:0EPS(TTM):0.35
Book Value(Rs):35.452956Market Cap ( Cr.):525.54Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 106.4080.59164.3562.2640.7441.18
Excise Duty0.000.000.000.000.000.00
Net Sales106.4080.59164.3562.2640.7441.18
Other Income 1.653.452.722.214.342.58
Stock Adjustments 0.791.210.40-2.040.28-0.60
Total Income108.8485.25167.4762.4345.3643.16
EXPENDITURE :      
Raw Materials 43.7330.2731.2721.4821.3021.64
Power & Fuel Cost3.923.573.882.912.522.22
Employee Cost 26.0117.4816.2213.0311.719.99
Other Manufacturing Expenses 2.532.812.252.271.401.05
Selling and Administration Expenses 15.2311.1812.045.635.434.13
Miscellaneous Expenses 1.268.066.261.9131.381.05
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure92.6873.3771.9347.2273.7440.08
Operating Profit16.1511.8895.5515.20-28.373.07
Interest 4.8011.5719.9225.5519.015.73
Gross Profit11.350.3175.63-10.35-47.38-2.66
Depreciation12.2913.5215.398.057.774.44
Profit Before Tax-0.94-13.2160.24-18.40-55.15-7.10
Tax1.600.210.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.26-0.1320.34-3.940.24-8.83
Reported Net Profit-2.27-13.2939.90-14.46-55.391.73
Extraordinary Items 0.04-7.06-3.09-1.43-27.63-0.53
Adjusted Net Profit-2.31-6.2342.99-13.03-27.762.26
Adjst. below Net Profit 0.000.000.000.000.00-0.27
P & L Balance brought forward-101.38-88.09-127.99-113.54-58.15-36.76
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down-103.65-101.38-88.09-127.99-113.54-35.29
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr-0.69-4.3313.91-5.04-19.310.62
Earnings Per Share(Adj)-Unit Curr-0.69-4.3313.91-5.04-19.310.62
Book Value-Unit Curr27.2819.2215.491.546.5534.77